Category: Covid-19 Vaccine

Page 317«..1020..316317318319..330340..»

European Union mulling mandatory COVID-19 vaccinations – Fox News

December 2, 2021

After two dozen countries have reported cases of the omicron variant, the European Union (EU) countries might be headed towards mandatory vaccination to fight the spread of COVID-19, according to head of EU commission.

Given only a third of the EU population is still unvaccinated, the head of EU commission Ursula von der Leyen said, "My personal position is I think it is understandable and appropriate to lead this discussion now."

European Commission President Ursula von der Leyen makes a statement on camera regarding Brexit negotiations, after a phone call with British Prime Minister Boris Johnson, at EU headquarters in Brussels, Saturday, Dec. 5, 2020. (Julien Warnand)

The EU has increased travel restrictions since the variant was first reported and as cases continue to spike across Europe, according to a recent report.

COVID-19 OMICRON VARIANT WON'T STOP NEW ZEALAND'S REOPENING PLANS, PRIME MINISTER SAYS

On November 26, the World Health Organization (WHO) designated the variant B.1.1.529 as a variant of concern, also called omicron, based on the evidence that omicron has several mutations that may increase its chance of transmissibility.

Closeup of Ruffled European Union Flag, European Union Flag Blowing in Wind. The EU is considering prohibiting Americans from traveling to its member countries as it begins to reopen its borders over coronavirus conditions in the United States.

But the WHO reiterated, its unclear if the omicron variant is indeed more transmissible or weather it causes more severe disease compared to other variants, including delta.

UNIVERSITY OF OXFORD ON OMICRON: NO PROOF OF COVID-19 VACCINES WON'T PREVENT AGAINST SEVERE DISEASE

"Preliminary data suggests that there are increasing rates of hospitalization in South Africa, but this may be due to increasing overall numbers of people becoming infected, rather than a result of specific infection with omicron. There is currently no information to suggest that symptoms associated with omicron are different from those from other variants," according the Sunday press release.

"Initial reported infections were among university studentsyounger individuals who tend to have more mild diseasebut understanding the level of severity of the omicron variant will take days to several weeks."

European Commission President Ursula von der Leyen speaks during a press statement at EU headquarters in Brussels, Tuesday, Sept. 8, 2020. The European Union's executive commission has proposed European Commission vice-president Valdis Dombrovskis to take over the post of EU trade commissioner following the resignation of Ireland's Phil Hogan. (Aris Oikonomou, Pool Photo via AP)

Some EU states are proactively taking steps towards mandatory vaccination, including Austria, which announced mandatory vaccinations from February next year, while Greece is levying fines against those who are unvaccinated over the age of 60 years old. France announced COVID-19 passes will be deactivated for those adults who have not received boosters, starting in mid January, according to the BBC report.

CLICK HERE TO GET THE FOX NEWS APP

"The most effective steps individuals can take to reduce the spread of the COVID-19 virus is to keep a physical distance of at least 1 meter from others; wear a well-fitting mask; open windows to improve ventilation; avoid poorly ventilated or crowded spaces; keep hands clean; cough or sneeze into a bent elbow or tissue; and get vaccinated when its their turn," according to the WHO press release.

See the original post:

European Union mulling mandatory COVID-19 vaccinations - Fox News

Hundreds of NYC correction officers to be suspended for failing to meet COVID-19 vaccination deadline – Fox News

December 2, 2021

New York Citys troubled jail system is facing more turmoil: the suspension of hundreds of corrections officers for failing to meet a Tuesday night deadline to get vaccinated against COVID-19.

The citys Department of Correction reported 77% of its uniformed staff had gotten at least one vaccine dose as of 5 p.m. Monday, the lowest of any city agency.

Corrections Department Commissioner Vincent Schiraldi said Wednesday morning that about 700 jail workers whove applied for religious or medical exemptions can continue to work while their cases are reviewed.

TRAVEL AMIDST OMICRON: WHO SAYS PEOPLE AGED 60 AND OLDER SHOULD DELAY TRAVEL TO CERTAIN AREAS

That leaves just under 1,100 uniformed staff who are unvaccinated and could be facing suspension, but Schiraldi said some of those workers are on long-term leave for other reasons and he did not know precisely how many workers were suspended for failing to comply with the mandate.

The deadline for jail workers to be vaccinated was delayed a month because of existing staffing shortages.

Workers who havent applied for an exemption and who failed to show proof of vaccination by 5 p.m. Tuesday were to be placed on unpaid leave and surrender any city-issued firearms and protective gear, officials said.

Mayor Bill de Blasio, who already imposed similar mandates for other city workers, said he expects the vaccination rate to rise as workers begin missing paychecks or their requests for an exemption are denied.

"I expect those numbers to up in a very substantial way in the days ahead," de Blasio told reporters at a virtual news conference Wednesday.

In anticipation of the impending mandate, de Blasio on Monday issued an emergency executive order designed to beef up jail staffing by authorizing a switch to 12-hour shifts from the normal 8-hour tours.

The president of the union for jail guards balked at that move saying it was "reckless and misguided." The union said it would sue to block the mandate the same tactic a police union tried in late October as the vaccine requirement for its officers neared. The police union lost and the mandate went into effect as scheduled.

The promised suspensions threaten to add to the problems at the city's jails, which includes the notorious Rikers Island complex.(AP Photo/Lynne Sladky, File)

FDA PANEL ENDORSES FIRST COVID-19 PILL

Benny Boscio Jr., the president of the Correction Officers Benevolent Association, said staffing in the city's jails is as bad or worse than it was in October, when de Blasio announced jail workers would have extra time to meet the vaccine mandate.

Fewer than 100 of a promised 600 guards have been hired, Boscio said, and none of them have started working in the jails. Resignations and retirements have piled up, and guards are continuing to work round-the-clock shifts, with no time for meals or rest, Boscio said.

Suspending jail workers over the vaccine mandate could be deadly, the union chief warned.

"To move forward with placing what little staff we do have on leave tomorrow would be like pouring gasoline on a fire, which will have a catastrophic impact on the safety of our officers and the thousands of inmates in our custody," Boscio said Tuesday.

TUCKER CARLSON: WE'RE IN FOR A WHOLE NEW PANDEMIC

The promised suspensions threaten to add to the problems at the city's jails, which includes the notorious Rikers Island complex. The jails, rotted by years of neglect, have spiraled out of control during the pandemic with staggering violence, self-harm and the deaths this year of at least 14 inmates the most since 2013.

The troubles have led to growing calls to overhaul or immediately close Rikers Island, which the city has said will be shuttered by 2027. The city on Tuesday announced it had awarded contracts for work on new jails in Manhattan, Queens, Brooklyn and the Bronx.

Last week, members of the House Oversight Committee, including New York Reps. Carolyn Maloney and Alexandria Ocasio-Cortez, sent letters to New York City district attorneys expressing "grave concerns" that excessive bail amounts were putting too many people in jail.

BIDEN REQUIRING STRICTER COVID TESTING OF LEGAL TRAVELERS EVEN AS ILLEGAL IMMIGRANTS HAVE GOTTEN A PASS

At the same time, staffing levels have dropped sharply during the pandemic. Uniformed personnel fell from a staff of 10,862 in 2017 to 8,388 in 2021. At one point in the summer, one-third of guards were out sick or medically unfit to work with inmates and an untold number of guards went AWOL, the city said.

The vaccine mandate for jail workers is taking effect as scientists are racing to learn more about the omicron variant, which was identified last week by researchers in South Africa. No cases have been detected in the United States, though de Blasio said he believes it's "very likely" there will eventually be cases reported in New York City.

De Blasio announced an additional vaccine mandate Monday for child care workers, reiterating his commitment to the mandates he's unveiled for almost the city's entire municipal workforce in recent months.

CLICK HERE TO GET THE FOX NEWS APP

The Department of Correction said it held town halls, called employees and gave them literature to encourage them to get vaccinated. It also offered a $500 bonus, parked a truck displaying a pro-vaccine message on a digital billboard at Rikers Island and recruited Dr. Anthony Fauci, the nations top infectious disease expert, author Piper Kerman and former New York Mets player Mookie Wilson to tape messages for the department encouraging workers to get the shots.

The campaign has moved the needle, with Monday's 77% vaccination total among jail workers up from 72% a week earlier and 46% in late October when the mandate was announced. Still, at all other city agencies, at least at least 86% of workers have received at least one vaccine dose and most agencies were reporting vaccination rates above 90% as of Monday.

Excerpt from:

Hundreds of NYC correction officers to be suspended for failing to meet COVID-19 vaccination deadline - Fox News

COVID Vaccine Eat This Not That

November 29, 2021

Experts warn about the mistakes people make with the COVID-19 vaccine. ETNT Health. Sure Signs You've Caught COVID After Your Vaccine. You may have a "breakthrough" case of COVID-19 and these are the signs. ETNT Health. Doctors Say "Do Not" Do This After Your COVID Booster.

Continue reading here:

COVID Vaccine Eat This Not That

Why Moderna refuses to share the rights for a COVID-19 vaccine developed with taxpayer funding – Milwaukee Independent

November 29, 2021

The outcome of the battle has important implications, not only for efforts to contain the pandemic but more broadly for drugs and vaccines that could be critical for future public health crises. I teach drug regulation and patent law at Saint Louis Universitys Center for Health Law Studies.

Moderna recently offered to share ownership of its main patent with the government to resolve the dispute. Whether or not this is enough to satisfy the governments claims, I believe the dispute points to serious problems in the ways U.S. companies bring drugs and vaccines to market.

U.S. was a major funder of the Moderna vaccine

Vaccines have played a crucial role in the response to the pandemic. In December 2020, Moderna became the second pharmaceutical company after Pfizer to obtain authorization from the Food and Drug Administration to market a COVID-19 vaccine in the United States. People have since grown so used to talking about the Moderna vaccine that a crucial element in the history of how it was developed risks being overshadowed: Moderna was not the sole developer of the vaccine.

Unlike many of the other pharmaceutical companies involved in the COVID-19 vaccine race, Moderna is a newcomer to drug and vaccine commercialization. Founded in Massachusetts in 2010, the company had never brought a product to market until the FDA authorized its COVID-19 vaccine last year. Throughout the 2010s, Moderna focused on the development of mRNA technology, attracting over US$2 billion in funding from pharmaceutical companies and other investors. It went public in 2018.

Even before the pandemic, research on both coronaviruses and vaccine candidates against emerging pathogens was a priority for agencies operating in the public health space. In 2015, the National Institute of Allergy and Infectious Diseases, an institute within the NIH, signed a cooperative R&D agreement with Moderna on basic research, including the development of new vaccines. The agreement resulted in an undisclosed amount of funding and assistance with research.

In addition, after the COVID-19 outbreak began Moderna also received almost $1 billion in funding from the Biomedical Advanced Research and Development Authority, which operates within the Department of Health and Human Services. This funding was specifically targeted to the development of a COVID-19 vaccine candidate.

Researchers have calculated that, collectively, the U.S. government has provided $2.5 billion toward the development and commercialization of Modernas COVID-19 vaccine.

U.S. and Moderna scientists working side by side

In addition to providing financial support, the federal government was instrumental in the development of Modernas vaccine for other reasons. Namely, federal scientists worked alongside Moderna scientists on different components of the vaccine. These contributions included working on dosing mechanisms, and the NIH said federal scientists created the stabilized spike proteins that are a key component of the vaccine made by Moderna.

The importance of the role played by federal scientists in their work with Moderna would soon become apparent. A 2019 agreement with a third party explicitly acknowledged this, alluding to mRNA vaccine candidates developed and jointly owned by NIAID and Moderna. And by late 2020, the U.S. government was calling it the NIH-Moderna COVID-19 vaccine.

While the U.S. government has spent money on COVID-19 vaccines made by other companies, its close involvement in the R&D stages of Modernas sets it apart.

How it became a patent dispute

As development of the vaccine progressed, Moderna applied for several patents, each one covering different components of the vaccine. U.S. law allows inventors to apply for patents on products or methods that are new, not obvious and useful. While some early modern vaccines like the polio vaccine developed by Jonas Salks team were not covered by patents, from the late 20th century onward it became very common for one or multiple patents to cover a newly developed vaccine.

In applying for some patents related to its vaccine, Moderna named National Institute of Allergy and Infectious Diseases scientists as co-inventors alongside Moderna scientists. This was the case, for example, in a patent application dated May 2020 for a relatively minor component of the vaccine.

However, in July 2021, Moderna made it clear that it would not name government scientists as co-inventors in a patent application covering a much more significant component of the vaccine: the mRNA sequence used to produce the vaccine, known as mRNA-1273.

Modernas position was that Moderna scientists alone had selected the sequence. The company informed the Patent and Trademark Office of its position in a 2020 statement. In November 2021, government officials publicly challenged the companys decision after months of failed negotiations with the company. Moderna then took to social media to defend its position, tweeting:

Just because someone is an inventor on one patent application relating to our COVID-19 vaccine does not mean they are an inventor on every patent application relating to the vaccine.

By contrast, the National Institutes of Health argued that three NIAID scientists Kizzmekia Corbett, Barney Graham and John Mascola had meaningfully contributed to the invention, though they have declined to publicly specify how. If true, patent law says they should be named co-inventors.

But this dispute is not merely about scientific principles or technical aspects of the law. While patents are also regarded as proxies for measuring scientific reputation, their most immediate and powerful effect is to give patent holders a significant amount of control over the covered technology in this case, the main component of the vaccine made by Moderna.

From a practical perspective, excluding federal scientists from the application means that Moderna alone gets to decide how to use the vaccine, whether to license it and to whom. If, by contrast, the government co-owns the vaccine, federal patent law allows each of the joint owners to engage in a variety of actions from making and selling the vaccine to licensing it without the consent of the other owners.

This is especially relevant in cases of product scarcity or potential pricing issues in connection with the commercialization of the vaccine. For instance, the U.S. would have the ability to allow more manufacturers to produce vaccines using the mRNA-1273 technology. In addition, it could direct vaccine doses wherever it likes, including to lower-income countries that have received few vaccines so far.

Broader implications

The ongoing battle between the government and an emerging star in the pharmaceutical industry is yet another episode in a complicated relationship between actors with complementary yet distinct roles in the production of drugs and vaccines. On the one hand, the federal government has long played a critical role in both performing and funding basic research. On the other, it does not have the resources and capacity to bring most types of new drugs and vaccines to market on its own.

The pharmaceutical industry thus plays an important and necessary role in drug innovation, which I believe should be rewarded although not boundlessly.

If the NIH is correct about co-ownership of the vaccine, then Moderna is unduly using a legal tool to achieve a position of market control a reward it does not deserve. This position of sole control becomes even more problematic in light of the significant amounts of public money that funded the development of this vaccine. This offset some of Modernas financial risk, even as the company projects to make $15 billion to $18 billion in revenue from vaccine sales in 2021 alone, with much more expected in 2022.

However, even if the NIH prevails in the patent dispute, it is important to understand the limitations of such a win. The U.S. would be in a position to license the vaccine, for example, and could do so by requiring that licensees agree to equitable distribution of vaccine doses.

But co-ownership would not enable the government to fix any of the other problems that currently affect the manufacturing and distribution of COVID-19 vaccines, such as scaling up production or building infrastructure to deliver vaccine doses.

In my view, the dispute is a reminder of the many problems embedded in how vaccines are made and delivered in the U.S. And it shows that when taxpayers fund basic research of a drug, they deserve more of the control and rewards when that drug succeeds.

Read the original:

Why Moderna refuses to share the rights for a COVID-19 vaccine developed with taxpayer funding - Milwaukee Independent

Covid-19 Vaccine Makers Assess Omicron Response – The Wall Street Journal

November 29, 2021

We are delighted that you'd like to resume your subscription.

You will be charged $ + tax (if applicable) for The Wall Street Journal. You may change your billing preferences at any time in the Customer Center or call Customer Service. You will be notified in advance of any changes in rate or terms. You may cancel your subscription at anytime by calling Customer Service.

Please click confirm to resume now.

More:

Covid-19 Vaccine Makers Assess Omicron Response - The Wall Street Journal

Moderna says its COVID-19 vaccine protective, safe in …

November 29, 2021

A healthcare worker holds a vial of the Moderna COVID-19 vaccine at a pop-up vaccination site operated by SOMOS Community Care during the coronavirus disease (COVID-19) pandemic in Manhattan in New York City, New York, U.S., January 29, 2021. REUTERS/Mike Segar//File Photo

Register

Oct 25 (Reuters) - Moderna Inc (MRNA.O) said on Monday its COVID-19 vaccine generated a strong immune response in children aged six to 11 years and that it plans to submit the data to global regulators soon.

Moderna said its two-dose vaccine generated virus-neutralizing antibodies in children and safety was comparable to what was previously seen in clinical trials of adolescents and adults. It cited interim data that has yet to be peer reviewed.

It was unclear when U.S. regulators will weigh in on the shot. The Moderna COVID-19 vaccine is authorized for adults over the age of 18 years and is waiting for a response to its June application for children aged 12 through 17.

Register

It is behind rivals Pfizer Inc (PFE.N) and BioNTech SE , whose vaccine has been authorized for ages 12 and up since May. A panel of outside advisers to the U.S. Food and Drug Administration will meet on Tuesday to decide whether to recommend Pfizer's vaccine in children aged five to 11 years.

Moderna said that in its trial of 4,753 participants, side effects were mostly mild to moderate in severity. The most common side effects were fatigue, headache, fever and injection site pain.

The company statement did not disclose any new information about cases of heart inflammation called myocarditis, a known side effect of mRNA vaccines.

The shots were 50 microgram doses, half the strength used in the primary vaccine series for adults and the same as the booster dose authorized for adults. It is higher than the 10 microgram dose Pfizer is planning for its vaccine in children.

Both the Moderna and Pfizer/BioNTech vaccines have been linked to myocarditis in young men.

Some studies have suggested the rate of incidence in recipients of the Moderna vaccine may be higher than in Pfizer recipients, perhaps because of the stronger dose of vaccine.

Sweden has paused the use of the Moderna vaccine for younger age groups because of the higher risk of myocarditis.

While children rarely become seriously ill or die from COVID-19, some do develop rare complications, and COVID-19 cases in unvaccinated children have risen due to the contagious Delta variant.

Children can also spread the virus, infecting those who are not protected by vaccines and giving the virus more room to develop new variations.

Moderna shares rose 2% in morning trading.

Register

Reporting by Manas Mishra in Bengaluru and Michael Erman in New Jersey; Editing by Shounak Dasgupta and Howard Goller

Our Standards: The Thomson Reuters Trust Principles.

See original here:

Moderna says its COVID-19 vaccine protective, safe in ...

Covid-19 Vaccine and Omicron Variant: Live Updates – The New York Times

November 29, 2021

Travelers wearing personal protective equipment arrive at Sydney International Airport in Australia, on Monday.Credit...James Gourley/EPA, via Shutterstock

The World Health Organization warned on Monday that global risks posed by the new Omicron variant of the coronavirus were very high, as countries around the world rushed to defend against its spread with a cascade of border closures and travel restrictions that recalled the earliest days of the pandemic.

Scotland and Portugal identified new cases of the highly mutated variant, and Japan joined Israel and Morocco in banning all foreign visitors, even as scientists cautioned that the extent of the threat posed by Omicron remained unknown and as the patchwork of travel measures were so far proving unable to stop its spread.

Many of the restrictions aimed at corralling Omicron, which was first identified last week by researchers in South Africa, were aimed at travelers from southern Africa, drawing accusations that Western countries were discriminating against a region that has already been set back by vaccine shortages caused by rich nations hoarding doses.

In a technical briefing note to member countries, the W.H.O. urged national authorities to step up surveillance, testing and vaccinations, reinforcing the key findings that led its technical advisers on Friday to label Omicron a variant of concern.

The agency warned that the variants high number of mutations including up to 32 variations in the spike protein meant that there could be future surges of Covid-19, which could have severe consequences.

Experts say that while the variant may be more transmissible than prior versions of the virus, existing vaccines are likely to offer protection from severe illness and death, although some countries, including Britain, were preparing to expand booster programs to protect more people.

The agency stressed the need for countries to accelerate vaccinations against Covid as rapidly as possible, particularly for vulnerable populations and for those who are unvaccinated or not fully vaccinated. It also called on health authorities to strengthen surveillance and field investigations, including community testing, to better determine Omicrons characteristics.

The recommendation underscored that the steps taken by some countries to wind down testing and tracing capacity in recent months as the pandemic appeared to be receding thanks to rising vaccination rates are moving in the wrong direction.

Testing and tracing remains fundamental to managing this pandemic and really understanding what youre dealing with, said Margaret Harris, a spokeswoman for the agency. Were asking all countries to really look for this variant, to look if people who have got it are ending up in hospital and if people who are fully vaccinated are ending up in hospital.

The briefing note adds that P.C.R. tests are an efficient tool for detecting the new variant because they do not require as long a wait for an outcome as genetic sequencing tests that require laboratory capacity not available in all countries.

Its very good news, Ms. Harris said. You can much more quickly spot whos got it.

But while the agency had previously cautioned against imposing travel bans, the briefing note took a more flexible line, calling for a risk-based approach to travel restrictions that could include modified testing and quarantine requirements. The agency said it would issue more detailed travel advice in the coming days.

Japan on Monday joined Israel and Morocco in barring all foreign travelers, and Australia delayed reopening its borders for two weeks, as more countries sealed themselves off in response to the new Omicron variant of the coronavirus.

The Japanese prime minister, Fumio Kishida, said that Japan would reverse a move earlier this month to reopen its borders to short-term business travelers and international students. Japan, the worlds third-largest economy, has been closed to tourists since early in the pandemic, a policy it has maintained even as other wealthy nations reopened to vaccinated visitors.

Some countries proceeded with their plans to reopen on Monday, like Singapore and Malaysia, which opened their land border. South Korea, on the other hand, announced that it was delaying any loosening of social distancing restrictions.

Australia said on Monday that it would delay by two weeks its plan to reopen its borders to international students, skilled migrants and travelers from Japan and South Korea. The country said it would use the delay, to Dec. 15, to study whether the Omicron variant is more dangerous than the Delta variant, which raced across the world earlier this year.

Israel reopened to vaccinated tourists only four weeks ago.

Hours after Israel announced its blanket ban over the weekend, Morocco said on Sunday that it would deny entry to all travelers, even Moroccan citizens, for two weeks beginning Monday. The country is banning all incoming and outgoing flights over the two-week period.

The moves by Japan, Israel and Morocco stood in contrast to those in places like the United States, Britain, Canada and the European Union, which have all announced bans on travelers only from southern Africa.

Meanwhile, Indonesia on Monday joined a small but growing list of countries to bar travel with Hong Kong as well as the southern African region. Hong Kong detected two cases of Omicron on Thursday, prompting India, Pakistan and other nations to impose a travel ban.

The travel bans have triggered resentment among Africans who believed that the continent was yet again bearing the brunt of panicked policies from Western countries, which had failed to deliver vaccines and the resources needed to administer them.

In Japan, all foreign travelers except those who are residents of the country will be barred from entering starting at midnight on Monday.

In Israel, all foreign nationals will be banned from entering for at least 14 days, except for urgent humanitarian cases to be approved by a special exceptions committee. Returning vaccinated Israelis will be tested upon landing and must self-quarantine for three days, pending results of another P.C.R. test. Unvaccinated Israelis will have to self-quarantine for seven days.

Israelis returning from countries classified as red, with high risk of infection, including most African countries, must enter a quarantine hotel until they receive a negative result from the airport test, then transfer to home quarantine (until they get a 7-day P.C.R. test result).

Ran Balicer, the chairman of an expert panel that advises the Israeli government on Covid-19 response, said the decision was temporary and was taken out of prudence.

Japan has yet to report any cases of the new variant, though it is studying a case involving a traveler from Namibia. Israel has identified at least one confirmed case of Omicron so far a woman who arrived from Malawi and testing has provided indications of several more likely cases in the country.

Aida Alami contributed reporting from Morocco, and Muktita Suhartono from Indonesia.

transcript

transcript

Enhanced surveillance has identified six cases of the Omicron variant in Scotland so far. Four of these are in Lanarkshire and two in greater Glasgow and Clyde. Now its important for me to stress that the contact tracing of these cases is still ongoing. However, at this stage, we know that not all of them have any recent travel history to, or known links with others who have traveled to, the countries in Southern Africa, where the variant was originally detected. This suggests that there might already be some community transmission of this variant in Scotland. But again, let me stress there is no evidence yet that this is sustained, nor any evidence from the enhanced surveillance that it is widespread at this stage.

Officials in Scotland confirmed on Monday that six cases of the Omicron variant of the coronavirus had been recorded in the country and that some of those infected had not traveled recently, suggesting that there was community transmission. But they said there was no evidence that the transmission was sustained or widespread.

All of the infected individuals are in isolation and none have been hospitalized, said Scotlands first minister, Nicola Sturgeon, who described the emergence of the highly mutated Omicron variant as the most challenging development of the pandemic for quite some time.

At an emergency news conference, Ms. Sturgeon said that she had asked Prime Minister Boris Johnson of Britain to convene a meeting of Britains top emergency committee, insisting that the moment called for collective, national vigilance.

In a joint letter to Mr. Johnson, she and the first minister of Wales urged tougher rules for travelers entering the United Kingdom: We need to work collectively and effectively as four nations to take all reasonable steps to control the ingress of the virus to the country and then to limit its spread.

Four cases have been identified in the Lanarkshire area and two in the Greater Glasgow and Clyde area, officials said. Health officials had not yet determined whether the variant had arrived in Scotland from overseas. The countrys health agency and local health protection teams are carrying out contact tracing to establish the origin of the cases, as well as identify people who might have been exposed.

Ms. Sturgeon said there was no evidence yet that any of the six confirmed cases in Scotland had links to the United Nations climate summit, which took place in Glasgow this month. If that were the case, she said, I think our surveillance efforts might be showing more cases.

Still, Ms. Sturgeon said, the event, which drew participants from around the world, had not been ruled out as the source of the variant in Scotland.

The first minister urged the public to use this as an opportunity to up compliance with all the restrictions in place. She added that further restrictions on regional travel in the lead-up to Christmas were not planned, but warned that could change.

I still hope, really fervently hope, to be having a normal Christmas with my family, she said. Can I say that with 100 percent certainty? No, but thats what I hope, and thats what I think we should all be hopeful for.

President Biden will give an update on the U.S. response to the Omicron variant on Monday, the White House said in a statement on Sunday evening, as top federal health officials urged unvaccinated Americans on get their shots and eligible adults to seek out boosters.

Appearing on morning talk shows on Sunday, Dr. Francis Collins, director of the National Institutes of Health, cautioned Americans that the emergence of Omicron and the uncertainty that surrounds it are reminders that the pandemic is far from over.

While the variant has yet to be detected in the United States, maintaining vigilance and safeguarding public health through inoculations, masking indoors and distancing, remains critical, he said.

I know, America, youre really tired about hearing those things, but the virus is not tired of us, Dr. Collins said. And its shape-shifting itself.

The White House said that President Biden met on Sunday with members of his Covid response team, including Dr. Anthony S. Fauci, the nations top infectious disease expert. With much still unknown about the Omicron variant, Dr. Fauci told the president that it would take approximately two more weeks to learn more about its transmissibility and severity, but said that he continues to believe that existing vaccines are likely to provide a degree of protection against severe cases of Covid, the White House said.

Dr. Collins stressed that inoculation remains the first line of defense, saying that there are good reasons to believe, based on previous variants, that current vaccines will provide sufficient protection.

Please, Americans, if youre one of those folks whos sort of waiting to see, this would be a great time to sign up, get your booster, Dr. Collins said on Fox. Or if you havent been vaccinated already, get started.

He also underlined other critical mitigation efforts, including indoor masking when around unvaccinated individuals and maintaining social distance, in slowing the spread.

Dr. Fauci delivered a similar message, sending a clarion call for vaccinations and boosters. It is inevitable that the variant, which has already been detected in several countries, will surface in the United States, Dr. Fauci said.

The question is, will we be prepared for it? Dr. Fauci said on ABCs This Week on Sunday morning. And the preparation that we have ongoing for what were doing now with the Delta variant just needs to be revved up.

Portugal on Monday said it had identified 13 cases of the Omicron variant of the coronavirus, all tied to Belenenses, a soccer club that was forced to take part in a top-flight game over the weekend that was abandoned while in progress.

The countrys national health institute said that the 13 people were isolating and that they were all players or staff members of Belenenses, which fielded a depleted team of only nine players against Benfica on Saturday after reporting a coronavirus outbreak.

The institute also confirmed that one of the 13 people was a player who had recently returned to Portugal from South Africa, whose scientists helped identify Omicron. Benficas players will be tested for the virus, the countrys general health director, Graa Freitas, told the local TSF radio station.

Before the game on Saturday, as many as 17 players and staff members of the Belenenses club tested positive for the virus, although it was unclear at the time whether those cases involved the new variant. The Belenenses players sought to have the game canceled, but officials reportedly told them that it had to go on.

Separately, Portugals health authorities said they were tracing more than 200 passengers who had arrived in Portugal on Saturday from Maputo, Mozambique. At least two people on the flight had tested positive for the virus, but the authorities said it was too early to confirm whether these were Omicron cases.

Portugal on Monday began suspending all flights to and from Mozambique, which is a former Portuguese colony and shares a border with South Africa, over concerns about the new variant.

Even before concerns about the new Omicron variant arose, China had refused calls to loosen its border restrictions, which are among the strictest in the world.

Now Chinese researchers are offering data to support the governments decision to maintain its extreme zero Covid strategy.

A recent study published on the countrys Center for Disease Control and Prevention website found that China could face more than 630,000 coronavirus cases a day if it dropped its zero-tolerance prevention measures and lifted curbs on travel, in the way that some Western countries have.

That would be more than five times as many as the total number of cases reported in China, which has a population of 1.4 billion, in the years since the virus first emerged in the central Chinese city of Wuhan, according to a New York Times database. Such an outbreak would put a huge strain on the countrys resources, including its hospital system, said the report, which was published before the World Health Organization labeled Omicron a variant of concern.

The authors of the report, who are scholars at Peking University in Beijing, wrote that the findings raised a clear warning that the country was not ready to open up.

More efficient vaccinations or more specific treatment, preferably the combination of both, are needed before entry-exit quarantine measures and other Covid-19 response strategies in China can be safely lifted, they wrote.

While China has vaccinated more than 75 percent of its population, questions have been raised about the efficacy of the countrys homegrown vaccines.

The Beijing government has staked much of its political legitimacy on controlling the virus better than other countries. The strategy, so far, has worked: China has reported fewer than 5,000 deaths since the pandemic began and has managed to quickly tame sporadic outbreaks through severe, and sometimes impractical, measures. On Monday, China reported just 21 locally transmitted cases, most of which were reported in the northern region of Inner Mongolia.

Source: Center for Systems Science and Engineering (CSSE) at Johns Hopkins University. The daily average is calculated with data that was reported in the last seven days.

While some critics have warned that Chinas approach could be unsustainable and counterproductive, growing concerns about the new Omicron variant now make it even more unlikely that Beijing will ease its restrictions, which include at least two weeks of mandatory quarantine for visitors as well as snap lockdowns and mass testing campaigns in areas where the virus is detected.

Dr. Zhang Wenhong, one of Chinas top infectious disease experts, said on Sunday that the countrys comprehensive approach to fighting the virus made it well placed to confront the evolving threat.

If we can cope with the Delta variant, we can also cope with Omicron, Dr. Zhang wrote on Weibo, a popular Chinese social media platform.

A woman sent a quarantine hotel in Queensland, Australia, up in flames by lighting a fire under a bed in her room, according to police, triggering the evacuation of the buildings 163 occupants.

Police charged the 31-year-old woman, who was quarantining in the Pacific Hotel in the city of Cairns with her two children, with arson on Sunday.

The fire was started at about 7 a.m. on Sunday in the womans room on the top floor of the hotel in far north Queensland, police said. It then spread to neighboring rooms.

The hotel was quickly evacuated, and there were no injuries, said Chris Hodgman, the Queensland Police acting chief superintendent, on Sunday afternoon. But the hotel had suffered significant damage, he said, and the residents needed to be moved to another quarantine facility.

Photos and videos posted to social media showed flames and thick smoke pouring out of two rooms on the hotels 11th floor.

Her two children, with whom she had been occupying the room for a few days after arriving from another state in the country, were being looked after by police, he added.

Authorities charged the woman with one count of arson and another of willful damage. She was expected to appear in a local court on Monday.

Anyone who arrives in Queensland from another state or overseas must quarantine for 14 days under the states pandemic borer restrictions. Those who have a house that fits government criteria around ventilation may undergo home quarantine, but those who do not must quarantine in a designated hotel and foot the bill themselves.

Source: Center for Systems Science and Engineering (CSSE) at Johns Hopkins University. The daily average is calculated with data that was reported in the last seven days.

The incident comes as rallies against pandemic measures continue to ramp up around Australia. On Saturday, police estimated that 20,000 people took to the streets of Melbourne to protest the state governments plans to introduce a bill that would extend its powers to impose pandemic restrictions. The previous weekend, thousands in the countrys state capitals rallied against vaccination requirements and coronavirus restrictions.

On Monday, Australia reported a third case of the Omicron coronavirus variant, in a traveler from South Africa quarantining in the Northern Territory. Two cases were discovered in travelers quarantining in New South Wales on Sunday.

As nations severed air links from southern Africa amid fears of another global surge of the coronavirus, scientists scrambled on Sunday to gather data on the new Omicron variant, its capabilities and perhaps most important how effectively the current vaccines will protect against it.

The early findings are a mixed picture. The variant may be more transmissible and better able to evade the bodys immune responses, both to vaccination and to natural infection, than prior versions of the virus, experts said in interviews.

The vaccines may well continue to ward off severe illness and death, although booster doses may be needed to protect most people. Still, the makers of the two most effective vaccines, Pfizer-BioNTech and Moderna, are preparing to reformulate their shots if necessary.

We really need to be vigilant about this new variant and preparing for it, said Jesse Bloom, an evolutionary biologist at the Fred Hutchinson Cancer Research Center in Seattle.

Even as scientists began vigorous scrutiny of the new variant, countries around the world curtailed travel to and from nations in southern Africa, where Omicron was first identified. Despite the restrictions, the virus has been found in a half-dozen European countries, including the United Kingdom, as well as Australia, Israel and Hong Kong.

Already, Omicron accounts for most of the 2,300 new daily cases in the province of Gauteng, South Africa, President Cyril Ramaphosa announced on Sunday. Nationally, new infections have more than tripled in the past week, and test positivity has increased to 9 percent from 2 percent.

Scientists have reacted more quickly to Omicron than to any other variant. In just 36 hours from the first signs of trouble in South Africa on Tuesday, researchers analyzed samples from 100 infected patients, collated the data and alerted the world, said Tulio de Oliveira, a geneticist at the Nelson R. Mandela School of Medicine in Durban.

Within an hour of the first alarm, scientists in South Africa also rushed to test Covid vaccines against the new variant. Now, dozens of teams worldwide including researchers at Pfizer-BioNTech and Moderna have joined the chase.

They wont know the results for two weeks, at the earliest. But the mutations that Omicron carries suggest that the vaccines most likely will be less effective, to some unknown degree, than they were against any previous variant.

The discovery the Omicron variant comes at a delicate moment for an airline industry that was just starting to see a rebound.

The question is whether the new coronavirus variant will deter travelers, as the Delta variant did this summer.

Several nations, including the United States, have banned visitors from South Africa and a handful of neighboring countries. Japan, Morocco and Israel have barred all incoming foreign visitors, while the Philippines has banned visitors from southern Africa and several European countries.

The international travel recovery has been slower than it has been in the United States. President Bidens decision to ease longstanding restrictions on foreign travelers this month promised to stimulate that rebound. It isnt yet clear how or whether the Omicron variant will affect travel demand, but if travel bans proliferate and concerns over the variant continue to spread, hopes for an accelerated international rebound could be dashed once again.

Only two U.S. carriers, Delta Air Lines and United Airlines, fly out of southern Africa. Both have said that they are not yet planning to adjust their schedules in response to the administration's ban, which takes effect on Monday and does not apply to American citizens or lawful permanent residents. Delta operates three weekly flights between Atlanta and Johannesburg. United operates five flights a week between Newark and Johannesburg, and it has not changed its plans to restart flights between Newark and Cape Town on Wednesday. None of the countries that have announced the new travel restrictions are major sources of business for U.S. carriers.

No major American airline has announced any substantive changes to procedures because of the variant. And all passengers flying into the United States must provide proof of a negative coronavirus test, with noncitizens also required to be fully vaccinated.

Within the United States, air travel has nearly recovered, even with many businesses still wary of sending employees on work trips. The number of people screened at airport security checkpoints over the past week was down only 10 percent from the same week in 2019, according to the Transportation Security Administration. And the industry successfully weathered the crush of travelers, avoiding the disruptions that at some airlines lasted for days in recent months.

In announcing on Monday that its borders would be closed to travelers from everywhere, Japan adopted a familiar tactic. The country has barred tourists since early in the coronavirus pandemic, even as most of the rest of the world started to travel again.

And it had only tentatively opened this month to business travelers and students, despite recording the highest vaccination rate among the worlds large wealthy democracies and after seeing its coronavirus caseloads plunge by 99 percent since August.

Now, as the doors slam shut again, Japan provides a sobering case study of the human and economic cost of those closed borders. Over the many months that Japan has been isolated, thousands of life plans have been suspended, leaving couples, students, academic researchers and workers in limbo.

Ayano Hirose has not been able to see her fianc, Dery Nanda Prayoga, in person for the past 19 months, since he left Japan for his native Indonesia, just two weeks after her parents blessed their marriage plans. The couple has made do with multiple daily video calls. When they run out of things to talk about, they play billiards on Facebook Messenger or watch Japanese variety shows together online.

We dont want to suffer in pain at the thought of not being able to reunite in the near future, said Ms. Hirose, 21, who has written letters to the foreign and justice ministries asking for an exemption to allow Mr. Dery to come to Japan. So we will think positively and continue to hold out hope.

See the rest here:

Covid-19 Vaccine and Omicron Variant: Live Updates - The New York Times

Social media on the acceptance of the COVID-19 vaccine | PPA – Dove Medical Press

November 29, 2021

Introduction

The Coronavirus (COVID-19) that results from the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a major international public health concern, with 179 million active cases and 3 million death recorded.1,2 The Centers for Disease Control and Prevention (CDC) in the United States raised concerns that a variant of SARS-CoV-2 known as B.1.1.7, which was initially discovered in England in late 2020, was found in ten US states. At the same time, there are several other variants identified, namely, B.1.351 and B.1.1.28.1,3 Presently, there is another variant found in India, which is named the delta variant (B.1.617.2).4 The spreading of the variants has become a major public health problem because of the potential impact on case rates, hospital capacities, and ultimately death.3 There has been a remarkable extent to which the pandemic has worsened current economic and health inequalities. However, the remarkable speed of developing several COVID-19 vaccines (AstraZeneca, Sinopharm, Sinovac, Pfizer, and Moderna vaccines) and their immediate authorization for emergency use in less than one year is a great achievement for the scientific community.5,6 Despite the overall favorable safety and effectiveness profiles of vaccines, the processes which have facilitated the rapid development have been a public concern with potential adverse impacts on vaccination acceptance that have led to the vaccine hesitancy.7 Although vaccine hesitation has a long history, it is reasonable to claim that today the Internet provides misinformation. Fear and misunderstandings of vaccine development and approvals likely make the spreading of misinformation easier.8,9

Social media are also used efficiently to notify the general population about the consequences of the pandemic. In addition, emerging infectious diseases like COVID-19 lead to enhanced public use and desire for all types of information from media. Social media thus has an important impact on perception of disease outbreaks, decision-making, and risk behavior.1012 As people share information on social media, such information can be accurate or inaccurate. Accurate and timely reporting on emerging risks such as SARS-CoV-2 is therefore essential to the public.13,14 In reaction to a global public health crisis, social media users generally develop and share information on healthcare available from local and international sources. Meanwhile, professionals and governments in the health sector have adopted social media to control and manage negative health crises.1517 However, various age groups prefer various social media sites, whereas the present study utilized Twitter, WhatsApp, and Facebook for data collection regarding the impact of social media on the vaccine. The World Health Organization (WHO) has declared that most of the social media platforms are sources of misinformation regarding the COVID-19 which may lead to significant risk to the public health.18 In Saudi Arabia, the Ministry of Health has launched a vaccine campaign using a mobile application entitled Sehaty, which makes it easier to register for COVID-19 vaccination. Several vaccination centers have also been built in various cities throughout the country. The Pfizer-BioNTech COVID-19 Vaccine campaign started on 17 December 2020 to supply all residents of Saudi Arabia with free vaccines.19 This study aims to understand the influence of social media on the attitudes and willingness of the general public of the Aseer region of Saudi Arabia to receive vaccination against COVID-19.

Following some earlier studies,2023 a self-administered, structured and closed questionnaire was established and afterward adapted to suit the common audience of the Saudi Arabia Aseer region. Then a pilot test was performed to ensure the validity of the survey and assess the language of the study carried out by a linguistic expert. The questionnaire was written in English and also translated into Arabic by a professional. It was made available to participants through several social media platforms (Twitter, WhatsApp, and Facebook). The data was collected in April and May 2021. Residents of Saudi Arabia who are over the age of 18 (eligible for COVID-19 Vaccination) and willing to participate in the survey were included in the study. The study excluded people who were not willing to give their consent. Data collection consisted of the following steps: Participants demographic characteristics and perspectives on the impact of social media on acceptance of the COVID-19 vaccine were collected, and their opinions on the effectiveness of the vaccination. A Google Form questionnaire was created for this study. A total of 613 persons willingly took part in the survey. The average amount of time required to complete the form was 5 minutes. A self-administered questionnaire was created, and the pilot sample was then tested for validation to ensure its quality and internal reliability. The Cronbach Alpha factor (calculated for 14 questions) was determined as 0.782. In addition, three experts working within this field provided advice regarding this process. The pilot study results were not included in the final analysis.

The questionnaires were reviewed, and the data were cleaned, coded, and inputted in the SPSS version 20 (IBM Corp., Armonk, NY, USA). The results were obtained through the application of both descriptive and inferential statistics. The questions in the questionnaire, if answered yes, were classified as either positive or negative impact of social media toward COVID-19 vaccines. For the positive attitude question, strongly agree and agree will be considered as positive attitude, while neutral, disagree, and strongly disagree will be negative attitude (control). Then, logistic regression was applied to identify independent factors associated with positive attitudes toward social media. The dependent factors are the questions with positive attitude toward social media, while independent factors included, sex, age, university level, and monthly income, employment status, and residence area. They were considered as a priori factors and were incorporated in the logistic regression model. Odds ratios (ORs) and 95% confidence intervals (CIs) were used to detect correlations between dependent and independent variables. P value < 0.05 was considered significant.

The data collection processes were standardized, and no personal information about the participants was collected or stored. The remaining information was kept confidential during the study as well as during data analysis. The participants were asked for their consent before the beginning of the survey. They were not asked about their ID nor any personal information. Participation in the study was completely voluntarily.

The World Medical Association [WMA] Declaration of Helsinki: Ethical standards for medical research involving human people, as amended by the 59th WMA (ECM#2021-5415), Seoul, Korea, was followed in this study. Aside from that, no personally identifiable information about the patients was collected. In addition, the Research Ethics Committee at King Khalid University (HAPO-06-B-001) has reviewed and agreed on this project: Approval No. ECM#2021-5415; Approval date 0205-2020.

The study questionnaire was completed by 613 participants who fulfilled the inclusion criteria, with ages ranging from 18 to >55 years old. Most of the participant were young adults (1825 years; 35.9%) followed by 2635 years (30.7%), 3645 years (22.8%), 4655 years (8.6%) and > 55 years (2%). Here, 370 participants (60.4%) were females, while 243 participants (39.6%) were males. Considering the level of education, 414 (67.5%) individuals graduated from university, followed by 17.8% for high school or lower and 14.7% for a postgraduate degree. The monthly income was less than 5000 SR for 241 (39.3%) participants, while 164 (26.8%) reported having 800015,000 SR monthly income (Table 1). Apart from that, the vast majority of those who took part were residents of urban areas (82.2%). However, 16% of participants reported being infected or contacted by an infected person during the past six months with the emerging COVID-19.

Table 1 Demographic Presentation of the Respondents

Table 2 presents the perspectives of the participants on the social media impact of getting the COVID-19 vaccine. Over half (74.6%) of participants agreed or strongly agreed that there was misinformation in the social media about the COVID-19 vaccination. Also, a similar percentage (72.8%) are agreed or strongly agreed that they would obtain the information directly from the competent authorities without referring to social media. However, 37% of participants strongly agreed that social media had increased the willingness to take the COVID-19 vaccine. In contrast, more than half of the participants demonstrated a negative attitude towards sharing vaccine information retrieved from social media. Most participants disagreed, strongly disagreed, or were neutral towards advising others to constantly follow social media to know the vaccines latest developments. Also, the participants agreed (21.8%) or strongly agreed (28%) that the amount and quality of information on social media negatively affect their psychological state.

Table 2 The Perspectives of the Participants on the Social Media Impact of Getting the COVID-19 Vaccine

Table 3 shows the questions in the questionnaire, if answered yes, were classified to either positive or negative impact of social media toward COVID-19 vaccines acceptance. Table 4 represents the logistic regression model which revealed a significant association between some independent variables and the positive attitude toward social media. Male participants were less likely to be influenced by social media when deciding to take COVID-19 vaccines (p=0.041, OR: 0.679, CI: 0.4680.985). Compared to participants with lower education level, participants with university education level or with postgraduate degree level were less likely to share information obtained from social media on the vaccine without making sure that the information were correct (p=0.01, OR: 0.546, CI: 0.3440.866) and (p=0.003, OR: 0.331, CI: 0.1580.693) respectively. Additionally, participants with postgraduate degree were in general less likely to have a positive attitude toward using of social media as s source of information regarding COVID-19 vaccine, see Tables 3 and 4.

Table 3 The Questions That Measure the Attitude Toward Social Media (SM)

Table 4 Logistic Regression Analysis for Examining Factors Affecting the Positive Attitude Toward Social Media Regarding COVID-19

Historically, vaccinations have led to the elimination of smallpox and significant decreases in rubella, mumps, polio, chickenpox, and various other infectious diseases. The COVID-19 pandemic resulted in over 100 million cases and more than 2 million deaths globally as of January 2021, and vaccination is likely to be vital in having pandemic prevention and management. Generally, the study of vaccinations illustrates the long gaps between scientific design, development, production, approval, and population-based use. The COVID-19 pandemic has sparked a surge in global vaccine research and development (R&D).5,6,2430 Several vaccines are available, including the AstraZeneca (Oxford), Sinopharm, Sinovac, Pfizer (BioNTech), and Moderna vaccines.6 Social media has become a stage for public opinion, perception, and attitudinal opinion on different events or policies relating to public health concerning COVID-19 due to the pandemic. Social media has become a helpful element for communicating critical information to governments, agencies, and academics. Several projects use social media information to track infectious disease outbreaks and assess public opinion attitudes, behavior, and perceptions.3135 The rapid and dynamic social media environment was used in this study to acquire Saudi Arabian perspectives into the COVID-19 vaccination, while the previous outlined was followed.2023

Social media was among the most common ways to learn about news and updates on infectious diseases in developing countries. During the COVID-19 pandemic, social media played a vital role in sharing reliable or misleading statements. In addition to the COVID-19 pandemic, there have been widespread misleading statements or information that presents a severe public health problem, which leads to modifying the patterns of infection and the extent and depth of the pandemic. To the best of our knowledge, this study is the first of a kind to explore the impact of social media on acceptance of COVID-19 vaccination in Saudi Arabia. All media could share this information, but the role played by social media in promoting misinformation should be of particular concern. In addition, scholars discovered misinformation about healthcare on social media sites, including information about vaccines and other virus epidemics.13,3639 In the present study, 46.8% (strongly agree) and 27.8% (agree) reported that social media carries wrong information regarding the COVID-19 vaccine, while it needs to be taken after consulting the healthcare professionals. Social media have taken initiatives from the beginning of the pandemic to prevent misinformation on their sites. Facebook has stated that it will remove all postings with false claims regarding coronaviruses and all vaccines. Twitter has added labels on tweets having misinformation about the COVID-19 vaccine and erasing misinformation, while YouTube is devoted to blocking content with false vaccines claimed.40 In the current study, those who have an education level up to university (67.5%) are more aware of sharing information about the vaccine that they got from social media (P=0.01). Similar negative attitudes in sharing information on social media is found for postgraduates (P=0.003). Saudi Arabians have a higher perception of the COVID-19 pandemics (75.7%) than non-Saudi Arabians (65.9%), according to the previous studies.41,42 The previous study reported that about 83.6% got their information about COVID-19 pandemics from official sources, while 68.7% trusted the information shared by the Saudi health ministry.42 Presently, 51.3% strongly agreed to obtain the information directly from competent authorities. Yet, despite the negative impact of the social media towards sharing information of COVID-19, there is a more significant advantage of social media in influencing the vaccination. The transparency and social debates about public health are made possible by social media. Consequently, the ability to exchange information about the vaccination experiences more than at any other moment in human history makes tracking positive and negative impacts of the vaccine easier for researchers.43 This study also found similar observations in participants, whereas more than 50% have a positive attitude towards getting information about vaccine recipients through social media. Postgraduate (P=0.001) are significantly aware of this impact. In the present study, more than 50% have a positive attitude toward taking the COVID-19 vaccine, which is lower than the vaccine hesitancy in the earlier study conducted in Saudi Arabia.19 Also, the follow-up with interest on the latest developments regarding the COVID-19 vaccine was found in positive attitudes towards social media. Social media may also be utilized more efficiently to update the public about the health information in the pandemic, while almost half of the participants demonstrated a negative attitude towards social media (30.1% neutral).

The COVID-19 pandemic led to immediate losses such as the breakdown of the health care system and the global economic situation. Moreover, the long-term alteration of social and economic activity has dramatically affected mental health. As social media has become a key source of information and communication, there is a spread of misinformation about COVID-19 on numerous online social platforms. According to recent studies, spreading misleading information is causing widespread panic among people in several countries. Several studies have demonstrated that social media can spread misinformation, alter peoples mentality, and indirectly create psychological traumas as observed by prior incidents.4449 In the present study, almost half of the participants showed a positive attitude and agreed that the amount and quality of information on social media negatively affect their psychological state. While it also stated that the actual meaning of the receiving of the COVID-19 vaccine is affected, whereas 45.1% of participants are strongly supportive. As a result, social media plays an important influence on peoples perceptions of disease exposure, decision-making process, and risk behaviors.11,12 There are some limitations to the outcomes of this study, while the major one was the study represents only the Aseer region of Saudi Arabia. It is possible that the use of social media in data collection decreased the diversity of the sample population.

This study gives an assessment of the extent of social media on COVID-19 vaccination among Aseer populations. There is a high degree of awareness indicated, but there is a possibility for spreading misleading information via social media. The likelihood for participants to be vaccinated increased through social media follow-up despite the negative impacts. Social media that can share up-to-date scientific information about vaccination must be utilized perfectly by the government to help people make decisions about accepting vaccines. The public should improve their awareness toward the correct medical information by consulting healthcare professionals or looking after the correct knowledge from reliable sources.

The authors would like to thank King Khalid University, Deanship of Scientific research for funding this research through grant number R.G.P.1/209/41 for small group research project.

The authors report no conflicts of interest in this work.

1. Tsao SF, Chen H, Tisseverasinghe T, Yang Y, Li L, Butt ZA. What social media told us in the time of COVID-19: a scoping review. Lancet Digit Health. 2021;3(3):e175e194. doi:10.1016/S2589-7500(20)30315-0

2. COVID-19 Coronavirus Pandemic. Available from: https://www.worldometers.info/coronavirus/. Accessed August 25, 2021.

3. Galloway SE, Paul P, MacCannell DR, et al. Emergence of SARS-CoV-2 B.1.1.7 Lineage - United States, December 29, 2020-January 12, 2021. MMWR Morb Mortal Wkly Rep. 2021;70(3):9599. doi:10.15585/mmwr.mm7003e2

4. Torjesen I. Covid-19: delta variant is now UKs most dominant strain and spreading through schools. BMJ. 2021;373:n1445. doi:10.1136/bmj.n1445

5. Basch CE, Basch CH, Hillyer GC, Meleo-Erwin ZC, Zagnit EA. YouTube Videos and Informed Decision-Making About COVID-19 Vaccination: successive Sampling Study. JMIR Public Health Surveillance. 2021;7(5):e28352. doi:10.2196/28352

6. Hou Z, Tong Y, Du F, et al. COVID-19 Vaccine Hesitancy, Confidence, and Public Engagement: a Global Social Listening Study. J Med Internet Res. 2021;23(6):e27632. doi:10.2196/27632

7. Kekatos M. Nearly 80% of Americans think that the speedy approval process of a coronavirus vaccine is driven by politicsNOT by proof that shots work. The Harris Poll. Available from: https://theharrispoll.com/nearly-80-of-americans-think-that-the-speedy-approval-process-of-a-coronavirus-vaccine-is-driven-by-politics-not-by-proof-that-shots-work/. Accessed March 1, 2020.

8. McAteer J, Yildirim I, Chahroudi A. The VACCINES Act: deciphering Vaccine Hesitancy in the Time of COVID-19. Clin Infect Dis. 2020;71(15):703705. doi:10.1093/cid/ciaa433

9. Harrison EA, Wu JW. Vaccine confidence in the time of COVID-19. Eur J Epidemiol. 2020;35(4):325330. doi:10.1007/s10654-020-00634-3

10. Freberg K, Palenchar MJ, Veil SR. Managing and sharing H1N1 crisis information using social media bookmarking services. Public Relat Rev. 2013;39(3):178184. doi:10.1016/j.pubrev.2013.02.007

11. Giustini D, Ali SM, Fraser M, Kamel Boulos MN. Effective uses of social media in public health and medicine: a systematic review of systematic reviews. Online J Public Health Inform. 2018;10(2):e215. doi:10.5210/ojphi.v10i2.8270

12. Al-Dmour H, Masadeh R, Salman A, Abuhashesh M, Al-Dmour R. Influence of Social Media Platforms on Public Health Protection Against the COVID-19 Pandemic via the Mediating Effects of Public Health Awareness and Behavioral Changes: integrated Model. J Med Internet Res. 2020;22(8):e19996. doi:10.2196/19996

13. Bridgman A, Merkley E, Loewen PJ, et al. The causes and consequences of COVID-19 misperceptions: understanding the role of news and social media. Harvard Kennedy School Misinformation Rev. 2020;1(3). doi:10.37016/mr-2020-38

14. Tang L, Bie B, Park SE, Zhi D. Social media and outbreaks of emerging infectious diseases: a systematic review of literature. Am J Infect Control. 2018;46(9):962972. doi:10.1016/j.ajic.2018.02.010

15. Reynolds BSM. Crisis and emergency risk communication as an integrative model. J Health Commun. 2005;10(1):4355. doi:10.1080/10810730590904571

16. Meadows CW, Meadows CZ, Tang L, Liu W. Unraveling public health crises across stages: understanding Twitter emotions and message types during the California measles outbreak. Commun Stud. 2019;70(4):453469. doi:10.1080/10510974.2019.1582546

17. Hu B, Zhang D. Channel selection and knowledge acquisition during the 2009 Beijing H1N1 flu crisis: a media system dependency theory perspective. Chin J Commun. 2014;7(3):299318. doi:10.1080/17544750.2014.926951

18. Infodemic management. World Health Organization; 2021. Available from: https://www.who.int/teams/risk-communication/infodemic-management. Accessed December 11, 2021.

19. Almaghaslah D, Alsayari A, Kandasamy G, Vasudevan R. COVID-19 Vaccine Hesitancy among Young Adults in Saudi Arabia: a Cross-Sectional Web-Based Study. Vaccines. 2021;9(4). doi:10.3390/vaccines9040330

20. Benis A, Khodos A, Ran S, Levner E, Ashkenazi S. Social Media Engagement and Influenza Vaccination During the COVID-19 Pandemic: cross-sectional Survey Study. J Med Internet Res. 2021;23(3):e25977. doi:10.2196/25977

21. Benis A, Seidmann A, Ashkenazi S. Reasons for Taking the COVID-19 Vaccine by US Social Media Users. Vaccines. 2021;9(4):315. doi:10.3390/vaccines9040315

22. Lee JJ, Kang KA, Wang MP, et al. Associations Between COVID-19 Misinformation Exposure and Belief With COVID-19 Knowledge and Preventive Behaviors: cross-Sectional Online Study. J Med Internet Res. 2020;22(11):e22205. doi:10.2196/22205

23. Eibensteiner F, Ritschl V, Nawaz FA, et al. Peoples Willingness to Vaccinate Against COVID-19 Despite Their Safety Concerns: twitter Poll Analysis. J Med Internet Res. 2021;23(4):e28973. doi:10.2196/28973

24. Greenwood B. The contribution of vaccination to global health: past, present and future. Philosophical transactions of the Royal Society of London. Series B Biol Sci. 2014;369(1645):20130433. doi:10.1098/rstb.2013.0433

25. Bloom DE, Cadarette D, Ferranna M, Hyer RN, Tortorice DL. How New Models Of Vaccine Development For COVID-19 Have Helped Address An Epic Public Health Crisis. Health Affairs. 2021;40(3):410418. doi:10.1377/hlthaff.2020.02012

26. Lurie N, Saville M, Hatchett R, Halton J. Developing Covid-19 Vaccines at Pandemic Speed. N Engl J Med. 2020;382(21):19691973. doi:10.1056/NEJMp2005630

27. Mukherjee SBD, Hamburg M, Weiss S, Yancopoulos G. Can a Vaccine for Covid-19 Be Developed in Record Time? New York Times Magazine. 2020;2:48.

28. Chou WS, Budenz A. Considering Emotion in COVID-19 Vaccine Communication: addressing Vaccine Hesitancy and Fostering Vaccine Confidence. Health Commun. 2020;35(14):17181722. doi:10.1080/10410236.2020.1838096

29. Gao Q, Bao L, Mao H, Wang L, Xu K, Yang M. Development of an inactivated vaccine candidate for SARS-CoV-2. Science. 2020;369(6499):7781. doi:10.1126/science.abc1932

30. Haque A, Pant AB. Efforts at COVID-19 Vaccine Development: challenges and Successes. Vaccines. 2020;8:4.

31. Prez-Escoda A, Jimnez-Narros C, Perlado-lamo-de-espinosa M, Pedrero-Esteban LM. Social Networks Engagement During the COVID-19 Pandemic in Spain: health Media vs. Healthcare Professionals. Int J Environ Res Public Health. 2020;17:14. doi:10.3390/ijerph17145261

32. Jordan SE, Hovet SE, Fung ICH, Liang H, Fu KW, Tse ZTH. Using Twitter for public health surveillance from monitoring and prediction to public response. Data. 2019;4(1):6. doi:10.3390/data4010006

33. Shah Z, Surian D, Dyda A, Coiera E, Mandl KD, Dunn AG. Automatically Appraising the Credibility of Vaccine-Related Web Pages Shared on Social Media: a Twitter Surveillance Study. J Med Internet Res. 2019;21(11):e14007. doi:10.2196/14007

34. Sinnenberg L, Buttenheim AM, Padrez K, Mancheno C, Ungar L, Merchant RM. Twitter as a Tool for Health Research: a Systematic Review. Am J Public Health. 2017;107(1):e1e8. doi:10.2105/AJPH.2016.303512

35. Steffens MS, Dunn AG, Wiley KE, Leask J. How organisations promoting vaccination respond to misinformation on social media: a qualitative investigation. BMC Public Health. 2019;19(1):1348. doi:10.1186/s12889-019-7659-3

36. Kim L, Fast SM, Markuzon N. Incorporating media data into a model of infectious disease transmission. PLoS One. 2019;14(2):e0197646. doi:10.1371/journal.pone.0197646

37. Radzikowski J, Stefanidis A, Jacobsen KH, Croitoru A, Crooks A, Delamater PL. The Measles Vaccination Narrative in Twitter: a Quantitative Analysis. JMIR Public Health Surveillance. 2016;2(1):e1e1. doi:10.2196/publichealth.5059

38. Fung ICH, Fu KW, Chan CH, et al. Social Medias Initial Reaction to Information and Misinformation on Ebola, August 2014: facts and Rumors. Public Health Rep. 2016;131(3):461473. doi:10.1177/003335491613100312

39. Sharma M, Yadav K, Yadav N, Ferdinand KC. Zika virus pandemic-analysis of Facebook as a social media health information platform. Am J Infect Control. 2017;45(3):301302. doi:10.1016/j.ajic.2016.08.022

40. Jimenez D. Covid-19 vaccines: the role of social media in disinformation. Pharmaceutical Technol. 2021;4:5487.

41. Al-Hanawi MK, Angawi K, Alshareef N, et al. Knowledge, Attitude and Practice Toward COVID-19 Among the Public in the Kingdom of Saudi Arabia: a Cross-Sectional Study. Front Public Health. 2020;8:217. doi:10.3389/fpubh.2020.00217

42. Alnasser AHA, Al-Tawfiq JA, Al Kalif MSH, et al. The positive impact of social media on the level of COVID-19 awareness in Saudi Arabia: a web-based cross-sectional survey. Le infezioni in medicina. 2020;28(4):545550.

43. Smith N Social media vital for COVID vaccine success. Available from: https://www.uwa.edu.au/news/article/2021/march/social-media-vital-for-covid-vaccine-success. Accessed November 25, 2021.

44. Hsiang S, Allen D, Annan-Phan S, et al. The effect of large-scale anti-contagion policies on the COVID-19 pandemic. Nature. 2020;584(7820):262267. doi:10.1038/s41586-020-2404-8

45. Bhattacharya C, Chowdhury D, Ahmed N, et al. The nature, cause and consequence of COVID-19 panic among social media users in India. Soc Netw Anal Min. 2021;11(1):53. doi:10.1007/s13278-021-00750-2

46. Garrett L. COVID-19: the medium is the message. Lancet. 2020;395(10228):942943. doi:10.1016/S0140-6736(20)30600-0

47. Ball P, Maxmen A. The epic battle against coronavirus misinformation and conspiracy theories. Nature. 2020;581(7809):371374. doi:10.1038/d41586-020-01452-z

48. Rosenberg H, Syed S, Rezaie S. The Twitter pandemic: the critical role of Twitter in the dissemination of medical information and misinformation during the COVID-19 pandemic. Cjem. 2020;22(4):418421. doi:10.1017/cem.2020.361

49.KadamAB, AtreSR. Negative impact of social media panic during the COVID-19 outbreak in India. J Travel Med. 2020;27(3):254. doi:10.1093/jtm/taaa057

Read more:

Social media on the acceptance of the COVID-19 vaccine | PPA - Dove Medical Press

Are covid-19 vaccines effective against the omicron variant? – Quartz

November 29, 2021

Travel bans and other restrictions are already in place globally after theWorld Health Organizationdesignated a strain of covid-19 first detected in Botswanaa variant of concern on Friday (Nov. 26).

Named omicron from the Greek alphabet, the variant contains over 30 mutations to its spike protein, which allows it to invade host cells and invite a response from the bodys immune system. At this stage little is known about whether its more contagious or dangerous than other strains, or the effectiveness of current covid-19 vaccines against it. But it may not be long before we do.

There are two key ways of looking at vaccine efficacy. One involves the extent to which the vaccine can reduce the number of cases that might otherwise have resultedthats the vaccines impact on transmission. The other more pressing question is the extent to which vaccines can reduce severe disease and hospitalization from this strain. Its possible to contract covid despite being vaccinatedwhats known as a breakthrough infectionbut with existing variants, vaccines mostly protect against serious illness.

Penny Moore, research chair of virus-host dynamics at South Africas University of the Witwatersrand, is leading a team that is already studying how this variant contends with antibodies. Moore told the journal Nature that theyre working at warp speed and hope to have some answers in as little as two weeks.

Scientists at Pfizer and BioNTech also say they are likely to know significantly more about how well their vaccine should be expected to workin about two weeks.

For comparison, the first known samples of delta,first detected in India, date from October 2020. It was labeled a variant of interest on April 4, 2021, and then became of concern on May 11. On May 22, Public Health England shared preliminary data about delta and vaccines. A subsequent study published in June, which used blood samples from vaccinated people to gauge the level of antibodies produced toward the original strain or to delta, found delta was far more likely to cause a breakthrough infection, but that the vaccines were still effective at preventing severe disease.

More answers about omicron will come from seeing how it spreads (or doesnt) in countries where delta is highly prevalent, given deltas ability to crowd out other strains of the virus and become dominant.

A South African doctor who helped discover omicron said that she has seen relatively mild symptoms so far, though its unclear if these were in vaccinated or unvaccinated patients. If data suggest that vaccines dont work as well with omicron, Pfizer and BioNTech say it would be possible to tweak their vaccine in a little over three months.

Go here to see the original:

Are covid-19 vaccines effective against the omicron variant? - Quartz

Page 317«..1020..316317318319..330340..»